Literature DB >> 15166542

Alpha-defensins inhibit HIV infection of macrophages through upregulation of CC-chemokines.

Chang-Jiang Guo, Ning Tan, Li Song, Steven D Douglas, Wen-Zhe Ho.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15166542      PMCID： PMC4035112          DOI： 10.1097/00002030-200405210-00020

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  15 in total

1.  Defensins and host defense.

Authors:  T Ganz
Journal:  Science       Date:  1999-10-15       Impact factor: 47.728

Review 2.  Mammalian defensins in immunity: more than just microbicidal.

Authors:  De Yang; Arya Biragyn; Larry W Kwak; Joost J Oppenheim
Journal:  Trends Immunol       Date:  2002-06       Impact factor: 16.687

3.  CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.

Authors:  G Alkhatib; C Combadiere; C C Broder; Y Feng; P E Kennedy; P M Murphy; E A Berger
Journal:  Science       Date:  1996-06-28       Impact factor: 47.728

4.  CD8+ T-cell-derived soluble factor(s), but not beta-chemokines RANTES, MIP-1 alpha, and MIP-1 beta, suppress HIV-1 replication in monocyte/macrophages.

Authors:  H Moriuchi; M Moriuchi; C Combadiere; P M Murphy; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

Review 5.  Controlling HIV pathogenesis: the role of the noncytotoxic anti-HIV response of CD8+ T cells.

Authors:  J A Levy; C E Mackewicz; E Barker
Journal:  Immunol Today       Date:  1996-05

6.  Primary CD8+ cells from HIV-infected individuals can suppress productive infection of macrophages independent of beta-chemokines.

Authors:  E Barker; K N Bossart; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

7.  Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

Authors:  Arya Biragyn; Pier Adelchi Ruffini; Cynthia A Leifer; Elena Klyushnenkova; Alexander Shakhov; Oleg Chertov; Aiko K Shirakawa; Joshua M Farber; David M Segal; Joost J Oppenheim; Larry W Kwak
Journal:  Science       Date:  2002-11-01       Impact factor: 47.728

8.  Interleukin-1beta stimulates macrophage inflammatory protein-1alpha and -1beta expression in human neuronal cells (NT2-N).

Authors:  Chang-Jiang Guo; Steven D Douglas; Jian-Ping Lai; David E Pleasure; Yuan Li; Marge Williams; Peter Bannerman; Li Song; Wen-Zhe Ho
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

9.  CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition.

Authors:  Theresa Li-Yun Chang; Fleur François; Arevik Mosoian; Mary E Klotman
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

10.  Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.

Authors:  Linqi Zhang; Wenjie Yu; Tian He; Jian Yu; Rebecca E Caffrey; Enrique A Dalmasso; Siyu Fu; Thang Pham; Jianfeng Mei; Jaclyn J Ho; Wenyong Zhang; Peter Lopez; David D Ho
Journal:  Science       Date:  2002-09-26       Impact factor: 47.728
View more
  21 in total

1.  Activation of NK cells by HIV-specific ADCC antibodies: role for granulocytes in expressing HIV-1 peptide epitopes.

Authors:  Vijaya Madhavi; Marjon Navis; Amy W Chung; Gamze Isitman; Leia H Wren; Robert De Rose; Stephen J Kent; Ivan Stratov
Journal:  Hum Vaccin Immunother       Date:  2013-01-16       Impact factor: 3.452

Review 2.  Mechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide development.

Authors:  Colleen R Eade; Matthew P Wood; Alexander M Cole
Journal:  Curr HIV Res       Date:  2012-01-01       Impact factor: 1.581

Review 3.  Modulation of HIV transmission by Neisseria gonorrhoeae: molecular and immunological aspects.

Authors:  Gary A Jarvis; Theresa L Chang
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

4.  Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensin.

Authors:  Lusine H Demirkhanyan; Mariana Marin; Sergi Padilla-Parra; Changyou Zhan; Kosuke Miyauchi; Maikha Jean-Baptiste; Gennadiy Novitskiy; Wuyuan Lu; Gregory B Melikyan
Journal:  J Biol Chem       Date:  2012-06-25       Impact factor: 5.157

5.  Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.

Authors:  Lingling Sun; Catherine M Finnegan; Tina Kish-Catalone; Robert Blumenthal; Paolo Garzino-Demo; Gian M La Terra Maggiore; Sid Berrone; Carol Kleinman; Zhibin Wu; Sayed Abdelwahab; Wuyuan Lu; Alfredo Garzino-Demo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 6.  Defensins in viral infections.

Authors:  Jian Ding; Yi-Ying Chou; Theresa L Chang
Journal:  J Innate Immun       Date:  2009-06-24       Impact factor: 7.349

7.  Increased alpha-defensins 1-3 production by dendritic cells in HIV-infected individuals is associated with slower disease progression.

Authors:  Marta Rodríguez-García; Núria Climent; Harold Oliva; Víctor Casanova; Rafael Franco; Agathe Leon; José M Gatell; Felipe García; Teresa Gallart
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

Review 8.  Innate immunity against HIV: a priority target for HIV prevention research.

Authors:  Persephone Borrow; Robin J Shattock; Annapurna Vyakarnam
Journal:  Retrovirology       Date:  2010-10-11       Impact factor: 4.602

9.  Plasma and mucosal HIV viral loads are associated with genital tract inflammation in HIV-infected women.

Authors:  Betsy C Herold; Marla J Keller; Qiuhu Shi; Donald R Hoover; Colleen A Carpenter; Ashley Huber; Urvi M Parikh; Kathy J Agnew; Howard Minkoff; Christine Colie; Marek J Nowicki; Gypsyamber DʼSouza; D Heather Watts; Kathryn Anastos
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

10.  Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.

Authors:  Mary E Klotman; Aprille Rapista; Natalia Teleshova; Amanda Micsenyi; Gary A Jarvis; Wuyuan Lu; Edith Porter; Theresa L Chang
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.